NxStage Medical Inc. (NSDQ:NXTM) inked a five-year deal with Nordic Medcom AB that will see the Swedish firm distribute NxStage’s System One home hemodialysis system in Scandinavia.
Lawrence, Mass.-based NxStage said the terms of the deal includes the exclusive right for Nordic Medcomm to sell the home dialysis system and its PureFlow SL dialysate preparation system to dialysis centers in Sweden, Denmark and Finland. Nordic Medcomm can also choose to sell NxStage’s Medisystems bloodlines and ButtonHole needles.
It’s the second European distribution deal for NxStage, following a similar, five-year pact with Kimal plc it inked last May for distribution in the U.K. and Ireland.
The company narrowed its third-quarter losses by more than 30 percent during the three months ended Sept. 30, as sales jumped 27 percent to $38 million, compared with $30 million for the same period in 2008. NxStage is slated to report its fourth-quarter results Feb. 25.
